Janssen joins CQDM drug discovery consortium

Janssen Inc (a division of Johnson & Johnson) has become the newest industrial consortium member of CQDM (formerly Quebec Consortium for Drug Discovery). Janssen's is the ninth pharmaceutical firm to join CQDM in pre-competitive research to develop tools and technologies for accelerating drug discovery. The firm will provide CQDM with cash and in-kind, participate in CQDM's growing mentorship program and engage with the Explore Program, a joint initiative of CQDM and the Ontario Centres of Excellence. In FY13, Janssen spent $67.4 million